- People aged 18 to 49 with underlying health conditions may be boosted at least six months after their Pfizer primary series, depending on their individual benefits and risks.
dadka da'doodu u dhaxayso 18-49 sano xaaladaha caafimaad ee salka ku haya waxaa laga yaabaa hel tallaalka xoojiyaha ee Pfizer-BioNTech COVID-19 ugu yaraan 6 bilood ka dib taxanahoodii koowaad ee Pfizer-BioNTech, oo ku salaysan faa'iidooyinkooda iyo khatartooda shaqsiyeed, iyo